Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Reeves, Barnaby C, Scott, Lauren J, Taylor, Jodi, Hogg, Ruth, Rogers, Chris A, Wordsworth, Sarah, Townsend, Daisy, Muldrew, Alyson, Peto, Tunde, Violato, Mara
et al (show 6 more authors) (2016) The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block triald. HEALTH TECHNOLOGY ASSESSMENT, 20 (80). 1-+.


Bailey, Clare, Scott, Lauren J, Rogers, Chris A, Reeves, Barnaby C, Hamill, Barbra, Peto, Tunde, Chakravarthy, Usha, Harding, Simon P ORCID: 0000-0003-4676-1158 and IVAN Study Group,
(2019) Intralesional Macular Atrophy in Anti–Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial. OPHTHALMOLOGY, 126 (1). pp. 75-86.


Bailey, Clare, Scott, Lauren J, Rogers, Chris A, Reeves, Barnaby C, Hamill, Barbra, Peto, Tunde, Chakravarthy, Usha and Harding, Simon P ORCID: 0000-0003-4676-1158
(2019) Re: Bailey et al: Intralesional macular atrophy in anti-vascular endothelial growth factor therapy for age-related macular degeneration in the IVAN trial (Ophthalmology. 2019;126:75-86) REPLY. OPHTHALMOLOGY, 126 (9). E72-E73.


Chakravarthy, Usha, Harding, Simon P ORCID: 0000-0003-4676-1158, Rogers, Chris A, Downes, Susan, Lotery, Andrew J, Dakin, Helen A, Culliford, Lucy, Scott, Lauren J, Nash, Rachel L, Taylor, Jodi
et al (show 6 more authors) (2015) A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN). HEALTH TECHNOLOGY ASSESSMENT, 19 (78). pp. 1-297.

This list was generated on Sat Aug 26 11:41:23 2023 BST.